Literature DB >> 1985747

Occult cancer in patients with deep venous thrombosis. A systematic approach.

M Monreal1, E Lafoz, A Casals, L Inaraja, E Montserrat, J M Callejas, A Martorell.   

Abstract

The authors prospectively studied 113 consecutive patients with deep venous thrombosis of the lower extremities to determine the most appropriate workup study for searching for a hidden cancer. After a careful physical examination, the following routine tests were performed: erythrocyte sedimentation rate (ESR), whole blood counts, biochemistry, carcinoembryonic antigen (CEA) levels, chest radiograph, upper gastrointestinal endoscopy, abdominal ultrasound and computed tomography (CT) scan. If a malignant lesion was suspected, further appropriate studies were performed. After discharge, periodic follow-up was performed on all patients in the outpatient clinic. A malignant neoplasm was detected in 12 patients. Of these 12 patients, six were asymptomatic with the exception of experiencing thrombophlebitis. Cancer was found more commonly in patients with idiopathic deep vein thrombosis (DVT) (7 of 31 versus 5 of 82 patients with secondary DVT; P = 0.012), and in those patients with abnormal lactic dehydrogenase (LDH) levels (6 of 23 versus 6 of 90; P = 0.007). Abnormal CEA levels allowed diagnosis of two cases of colonic cancer (on colonoscopy). Both ultrasound and CT scan of the abdomen showed two cases of urinary bladder carcinoma at a very early stage. Furthermore, two cases of adenomatous polyps in colon were found, a condition considered by most authors to be a colorectal cancer precursor. In addition, there were five patients with large benign pelvic tumors, and two patients with absent inferior vena cava. The most striking finding was that some cases of cancer were at a very early stage. It was concluded that blood cell counts, LDH, CEA, chest radiograph, and abdominal ultrasonography (or CT scan) should be routinely performed on all patients with deep venous thrombosis (particularly those with idiopathic DVT). Malignancy would not have been recognized in some patients if these tests had not been performed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985747     DOI: 10.1002/1097-0142(19910115)67:2<541::aid-cncr2820670237>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Should we look further for cancer in a patient with venous thromboembolism?

Authors:  D E Arterburn; W S Richardson
Journal:  West J Med       Date:  2000-05

2.  [Special aspects for preventing thromboembolism in surgical dermatology].

Authors:  R Rompel; E Rabe; I Hackert; G Sebastian
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

3.  Screening for cancer in venous thromboembolic disease.

Authors:  T Fennerty
Journal:  BMJ       Date:  2001-09-29

4.  Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness.

Authors:  D Arioli; M Pipino; E Boldrini; E Amateis; A Cristani; P Ventura; E Romagnoli; M C De Santis; M L Zeneroli
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

5.  Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism.

Authors:  P A Routledge; H G Shetty; J P White; P Collins
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 6.  The hypercoagulable state of malignancy: pathogenesis and current debate.

Authors:  Graham J Caine; Paul S Stonelake; Gregory Y H Lip; Sean T Kehoe
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 7.  The Role of Inferior Vena Cava Filters in Cancer Patients.

Authors:  Mithil B Pandhi; Kush R Desai; Robert K Ryu; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2016-06       Impact factor: 1.513

Review 8.  Venous thromboembolic disease and cancer.

Authors:  A Fennerty
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

9.  Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

Authors:  C K Goldman; J Kim; W L Wong; V King; T Brock; G Y Gillespie
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

10.  Deep venous thrombosis and occult malignancy: an epidemiological study.

Authors:  M Nordström; B Lindblad; H Anderson; D Bergqvist; T Kjellström
Journal:  BMJ       Date:  1994-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.